NCT02739659

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 73 (estimated)
• Sponsor: Shanghai Proton and Heavy Ion Center · Academic / Other
• Sex: Male
• Age: 20 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The aim of this research project is to assess the feasibility and safety of carbon-ion radiotherapy (CIRT) for the treatment of in Chinese localized prostate cancer

Detailed description

The purpose of this study is to determine the maximal tolerated dose (MTD) of CIRT in the treatment of localized prostate cancer and to evaluate the efficacy of such treatment at the MTD. Participants will be treated with CIRT with escalating dose regimens to evaluate the maximal tolerated dose (MTD) in terms of acute and subacute toxicity observed during and within 6 months after the completion of CIRT. Once the MTD for localized prostate cancer is determined, the MTD will be used as the recommended dose to patients fulfilling the inclusion criteria in the Phase II part of the trial.

Conditions

• Prostate Carcinoma

Interventions

Type	Name	Description
DEVICE	carbon-ion radiotherapy

Timeline

• Start date: 2016-01-01
• Primary completion: 2022-12-01
• Completion: 2024-12-31
• First posted: 2016-04-15
• Last updated: 2021-11-19

Locations

1 site across 1 country: China